Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 352
1.
Am J Case Rep ; 24: e941623, 2023 Nov 04.
Article En | MEDLINE | ID: mdl-37924204

BACKGROUND An 82-year-old woman presented with acute pyrexial illness and mesenteric panniculitis and developed biochemical aseptic meningitis (cerebrospinal fluid pleocytosis with no identifiable pathogen). Investigation determined her illness was likely a delayed hypersensitivity reaction caused by sulfasalazine. Sulfasalazine-induced aseptic meningitis is a rare condition often diagnosed late in a patient's admission owing to initial non-specific illness symptomatology requiring the exclusion of more common "red flag" etiologies, such as infection and malignancy. CASE REPORT An 82-year-old woman with a history of recurrent urinary tract infections and seronegative arthritis presented with a 3-day history of fatigue, headache, dyspnea, and lassitude. On admission, she was treated as presumed sepsis of uncertain source owing to pyrexia and tachycardia. Brain computer tomography (CT) revealed no acute intracranial abnormality. Furthermore, CT of the chest, abdomen, and pelvis did not reveal any source of sepsis or features of malignancy. After excluding infective etiologies with serological and cerebrospinal fluid testing, sulfasalazine-induced aseptic meningitis (SIAM) was diagnosed. The patient was then commenced on intravenous steroids, resulting in immediate defervescence and symptom resolution. CONCLUSIONS SIAM remains a diagnostic challenge since patients present with non-specific signs and symptoms, such as pyrexia, headaches, and lassitude. These patients require a thorough investigative battery starting with anamnesis, physical examination, biochemical testing, and radiologic imaging. This case illustrates the need for a high suspicion index of drug-induced hypersensitivity reaction in a rheumatological patient with pyrexial illness where infective etiologies have been confidently excluded. Prompt initiation of intravenous steroids in SIAM provides a dramatic recovery and resolution of symptoms.


Arthritis , Hypersensitivity, Delayed , Meningitis, Aseptic , Neoplasms , Panniculitis, Peritoneal , Sepsis , Female , Humans , Aged, 80 and over , Meningitis, Aseptic/chemically induced , Meningitis, Aseptic/diagnosis , Sulfasalazine/adverse effects , Panniculitis, Peritoneal/complications , Fever/chemically induced , Fever/complications , Sepsis/complications , Neoplasms/complications , Fatigue , Hypersensitivity, Delayed/complications , Steroids
2.
Pediatr Allergy Immunol Pulmonol ; 36(2): 46-49, 2023 06.
Article En | MEDLINE | ID: mdl-37184911

We report a case of a 15-year-old atopic patient presenting with delayed, severe ulcerative hypertrophic gingivitis after placement of orthodontic braces, which required removal of braces and restorative laser surgical procedures. Patch testing to multiple metals and chemicals showed weak positive reactions to steel bands and formaldehyde. The patient experienced urticarial, gingivitis, and other intraoral symptoms after patch testing and re-exposure to nickel-containing products. In contrast, nickel, cobalt, and cobalt-chromium (Co-Cr) bracket patch testing sites were negative. Nickel-caused contact dermatitis is Type IV delayed hypersensitivity reaction occurring at least 24 h after exposure. This reaction can result in intraoral blisters, ulcerations, eczematous and urticarial reactions of the face and more distant skin areas. This case illustrates the intraoral delayed response, symptom resolution after removing the braces, and brackets and local reactions upon subsequent nickel exposure, despite negative patch testing and lymphocyte stimulation test to nickel. This case further illustrates the difficulty associated with diagnosing nickel allergy.


Dermatitis, Contact , Gingivitis , Hypersensitivity, Delayed , Hypersensitivity, Immediate , Orthodontic Brackets , Humans , Adolescent , Nickel/adverse effects , Orthodontic Brackets/adverse effects , Dermatitis, Contact/etiology , Hypersensitivity, Delayed/etiology , Hypersensitivity, Delayed/complications , Cobalt/adverse effects , Hypersensitivity, Immediate/complications , Gingivitis/etiology , Gingivitis/complications
3.
Orbit ; 42(4): 455-458, 2023 Aug.
Article En | MEDLINE | ID: mdl-35576315

Skin rejuvenation procedures have increasingly flooded the aesthetic market, one of which includes microneedling. In microneedling, multiple fine punctures of the skin are performed with a needle to induce neocollagenesis. Microneedling has increasingly been used to treat inflammatory acne, acne scarring, photodamaged skin, and even radiation dermatitis. We present a patient with a stable history of liquid injectable silicone (LIS) given 20 years prior who developed chronic periocular and facial hypersensitivity after undergoing microneedling at a medi-spa. Long-term steroids and immunosuppressants were needed for control. The patient's severe reaction and resistance to treatment highlights the potential complications of microneedling administered by a non-medical professional in the setting of prior injectable silicone.


Acne Vulgaris , Cosmetic Techniques , Hypersensitivity, Delayed , Humans , Cosmetic Techniques/adverse effects , Silicones/adverse effects , Cicatrix/etiology , Acne Vulgaris/therapy , Acne Vulgaris/complications , Hypersensitivity, Delayed/complications , Treatment Outcome
5.
J Psychiatr Pract ; 28(2): 166-169, 2022 Mar 03.
Article En | MEDLINE | ID: mdl-35238828

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe cutaneous drug hypersensitivity reaction. Delays in making a diagnosis of DRESS syndrome and lack of timely treatment may result in morbidity and mortality. However, the presentation can be misinterpreted as other pathologies because of a broad spectrum of clinical presentations, delayed reactions, and prolonged course. Despite the discontinuation of the medication that is the culprit, relapses of drug reactions frequently occur weeks to months later. Several drugs that are associated with DRESS syndrome are prescribed as psychotropic medications. This report describes the case of a patient with DRESS syndrome who was evaluated with the RegiSCAR scoring system as a "definite case," which was possibly induced by carbamazepine prescribed to treat bipolar I disorder. The young female patient was successfully treated with steroid medication after carbamazepine was discontinued. She was prescribed aripiprazole for mood stabilization without a subsequent recurrence of DRESS syndrome. We recommend that, in cases such as described here, clinicians take DRESS syndrome into consideration and provide proper timely management, particularly for patients receiving psychotropic drugs. A brief review of the literature concerning DRESS syndrome associated with psychotropic drugs and its pathogenesis are outlined and discussed.


Drug Hypersensitivity Syndrome , Hypersensitivity, Delayed , Aripiprazole , Benzodiazepines , Carbamazepine/adverse effects , Drug Hypersensitivity Syndrome/diagnosis , Drug Hypersensitivity Syndrome/drug therapy , Drug Hypersensitivity Syndrome/etiology , Female , Humans , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/diagnosis
6.
J Investig Med High Impact Case Rep ; 10: 23247096221077836, 2022.
Article En | MEDLINE | ID: mdl-35225032

Many pediatric rheumatic diseases can be safely managed with biologic therapy. Severe allergic reactions to these medications are uncommon. We report the case of a 2-year-old male with systemic-onset juvenile idiopathic arthritis and secondary macrophage activation syndrome (MAS), whose treatment was complicated by severe allergic reactions to biologics, including drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity reaction (DIHR) likely due to anakinra, and anaphylactoid reaction to intravenous tocilizumab. These required transition to canakinumab, cyclosporine, and corticosteroids, with later development of interstitial lung disease and MAS flare needing transition from canakinumab to tofacitinib, which led to disease control. Whether lung disease is a manifestation of DRESS/DIHR to canakinumab remains unclear. High index of suspicion of hypersensitivity reactions for timely diagnosis and drug discontinuation is critical, especially in patients with active disease who might be at increased risk of these adverse events.


Antirheumatic Agents , Arthritis, Juvenile , Biological Products , Hypersensitivity, Delayed , Hypersensitivity , Macrophage Activation Syndrome , Antirheumatic Agents/adverse effects , Arthritis, Juvenile/complications , Arthritis, Juvenile/drug therapy , Biological Products/adverse effects , Child, Preschool , Humans , Hypersensitivity/complications , Hypersensitivity/drug therapy , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/drug therapy , Macrophage Activation Syndrome/chemically induced , Macrophage Activation Syndrome/complications , Macrophage Activation Syndrome/drug therapy , Male
7.
J Allergy Clin Immunol Pract ; 10(6): 1506-1514.e2, 2022 06.
Article En | MEDLINE | ID: mdl-35074602

BACKGROUND: Observation of the natural history of two emerging endotypes of allergic rhinitis, local-sensitization rhinitis (LAR) and dual-allergic rhinitis (DAR), compared with systemic-sensitization rhinitis (AR), could improve knowledge of the role of allergy in chronic rhinosinusitis with nasal polyps (CRSwNP). OBJECTIVE: To test the hypothesis that endotypes of Dermatophagoides pteronyssinus (DP)-induced rhinitis were risk factors for CRSwNP and adult-onset asthma and to investigate whether delayed hypersensitivity to DP, assessed by atopy patch test, could be a contributing factor. METHODS: We conducted a prospective observational study over 15 years on a cohort of 999 patients: 468 with AR, 333 with LAR, and 198 with DAR. The latter endotype was characterized by the coexistence of seasonal disease caused by systemic sensitization to pollen in patients with DP-induced LAR. The study design included a physical visit; ear, nose, and throat examination with anterior rhinoscopy; skin prick test; serum-specific IgE; DP-atopy patch test; nasal allergen provocation test with DP; paranasal sinuses computed tomography scan; nasal endoscopy; and spirometry. RESULTS: During 15 years of follow-up, 194 patients developed CRSwNP with a higher rate of LAR (28.2%) and DAR (22.2%) than AR (12%). For LAR and DAR, 7.5% and 10.6% of patients developed adult-onset asthma temporally linked to CRSwNP in 68% and 71.4% of cases, respectively. A total of 858 patients with rhinitis had delayed hypersensitivity to DP. Moreover, DP-ATP was an independent predictive factor for CRSwNP and had elevated positive and negative predictive values for localized allergic disease of the nasal mucosa. CONCLUSIONS: Endotypes of DP-induced allergic rhinitis represent risk factors for CRSwNP. Patients with local-sensitization rhinitis and DAR are more at risk than those with AR. In these emerging endotypes, progression toward CRSwNP is often associated with the development of adult-onset asthma. Chronic rhinosinusitis with nasal polyps shows several possible indicators for type 2 endotype. Delayed hypersensitivity to DP is an independent predictive factor for CRSwNP.


Asthma , Hypersensitivity, Delayed , Hypersensitivity, Immediate , Nasal Polyps , Rhinitis, Allergic, Perennial , Rhinitis, Allergic , Rhinitis , Sinusitis , Adult , Animals , Asthma/diagnosis , Chronic Disease , Dermatophagoides pteronyssinus , Humans , Hypersensitivity, Delayed/complications , Hypersensitivity, Immediate/complications , Immunoglobulin E , Nasal Polyps/complications , Nasal Polyps/epidemiology , Rhinitis/complications , Rhinitis/epidemiology , Rhinitis, Allergic/diagnosis , Sinusitis/diagnosis
8.
Acta Clin Belg ; 77(4): 785-786, 2022 Aug.
Article En | MEDLINE | ID: mdl-34556010

Following intravenous contrast medium (CM) injection, a small proportion of patients acquires hypersensitivity reactions that occur either immediately or non-immediately (delayed). Although it is now claer that even oral applied CMs are able to cause adverse reactions, many radiologists as well as physicians of other disciplines, still believe that CM-application via the gastrointestinal route does not induce hypersensitivity reactions. Since this kind of misinterpretation may harm the patient, education on this topic is still necessary. Therefore, we describe a case who acquired a delayed hypersensitivity reaction following the oral intake of a non-ionic iodinated CM.


Drug Hypersensitivity , Hypersensitivity, Delayed , Hypersensitivity, Immediate , Contrast Media/adverse effects , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Humans , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/diagnosis , Hypersensitivity, Immediate/chemically induced , Hypersensitivity, Immediate/complications , Hypersensitivity, Immediate/diagnosis
9.
Int Arch Allergy Immunol ; 181(6): 456-461, 2020.
Article En | MEDLINE | ID: mdl-32316004

BACKGROUND: The etiology of ulcerative colitis (UC) remains elusive even though many genetic and environmental pathogenic factors have been reported. Aberrant inflammatory responses mediated by specific subsets of T cells have been observed in ulcerative lesions of UC patients. OBJECTIVES: To elucidate the involvement of a delayed-type hypersensitivity reaction in UC, we focused on dental metal hypersensitivity, a T cell-mediated, delayed-type allergic reaction that causes oral contact mucositis and systemic cutaneous inflammation. METHOD: We recruited 65 Japanese UC patients and 22 healthy controls (HC) and used the in vitro lymphocyte stimulation test to quantify their sensitivity to zinc, gold, nickel, and palladium - the metals that have been widely used in dentistry. All subjects were users of metallic dental implants and/or prostheses containing zinc, gold, nickel, and/or palladium as major constituents. RESULTS: Sixty percent of the UC patients were hypersensitive to at least one metal species, whereas 32% of the HC were hypersensitive to only a single metal species. The overall incidence of metal hypersensitivity was significantly higher for UC patients than for HC. Furthermore, a significantly greater proportion of UC patients were hypersensitive to nickel or palladium. The severity of the sensitivity to nickel and palladium was also significantly greater for UC patients than for HC. CONCLUSIONS: This pilot study demonstrates that UC patients have a significantly higher incidence of hypersensitivity to nickel and palladium, suggesting the possible involvement of dental metal hypersensitivity in UC pathogenesis.


Colitis, Ulcerative/immunology , Dental Materials/adverse effects , Hypersensitivity, Delayed/complications , Nickel/immunology , Palladium/immunology , Adolescent , Adult , Aged , Case-Control Studies , Child , Female , Gold/adverse effects , Gold/immunology , Humans , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/diagnosis , Hypersensitivity, Delayed/epidemiology , Incidence , Male , Middle Aged , Nickel/adverse effects , Palladium/adverse effects , Pilot Projects , Prevalence , Young Adult , Zinc/adverse effects , Zinc/immunology
10.
Pediatr Dermatol ; 37(2): 375-376, 2020 Mar.
Article En | MEDLINE | ID: mdl-31876002

Lichen planus pigmentosus is uncommon in childhood and its treatment is often challenging. We report a case of cutaneous lichen planus pigmentosus in a 10-year-old boy, without oral mucosal involvement, two months after an amalgam dental restoration. The diagnosis was based on the histopathological examination of a skin biopsy, the positive patch test to mercury, and the improvement after amalgam removal. Our case report suggests that metal allergy may play a role, and amalgam replacement may be followed by clinical improvement.


Dental Amalgam/adverse effects , Hyperpigmentation/etiology , Hyperpigmentation/pathology , Hypersensitivity, Delayed/complications , Lichen Planus/etiology , Lichen Planus/pathology , Child , Humans , Hypersensitivity, Delayed/diagnosis , Male , Patch Tests
11.
Internist (Berl) ; 60(8): 821-839, 2019 Aug.
Article De | MEDLINE | ID: mdl-31286163

Acute interstitial nephritis (AIN) is a rare, often underdiagnosed condition and a common cause of renal failure. Drugs are the leading cause. The underlying pathophysiological condition is often a type IV hypersensitivity reaction. There are also rarer idiopathic forms, which often remain unrecognized. Additionally, the pathophysiological mechanisms are poorly understood, so that only very few promising forms of treatment are available. For some medications the overall risk is low but the side effects are relevant for the clinical routine due to the fact that they are frequently prescribed. In addition, the development of new approaches, such as immunotherapy also leads to side effects that cannot be completely predicted. For many diseases the occurrence of acute kidney injury increases the mortality and morbidity. A potentially irreversible chronic renal failure increases the incidence of further comorbidities and reduces the quality of life. Treatment is difficult and mostly empirical.


Acute Kidney Injury/etiology , Nephritis, Interstitial/complications , Nephritis, Interstitial/physiopathology , Renal Insufficiency, Chronic/etiology , Acute Kidney Injury/physiopathology , Drug-Related Side Effects and Adverse Reactions , Humans , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/physiopathology , Nephritis, Interstitial/prevention & control , Quality of Life , Renal Insufficiency, Chronic/physiopathology
12.
J Allergy Clin Immunol Pract ; 5(3): 669-675, 2017.
Article En | MEDLINE | ID: mdl-28483317

BACKGROUND: Penicillins are the drug family most commonly associated with hypersensitivity reactions. Current guidelines recommend negative skin tests (ST) before re-administering penicillins to patients with previous nonimmediate reactions (NIR). OBJECTIVE: The objective of this study was to examine whether ST are necessary before re-administering penicillin to patients with NIR. METHODS: Patients with NIR to penicillins starting longer than 1 hour after last dose administration or starting any time after the first treatment day or patients with vague recollection of their reaction underwent penicillin ST. Disregarding ST results, patients were challenged with the relevant penicillins. One-tenth of the therapeutic dose followed by the full dose was administered at 1-hour interval and patients continued taking the full dose for 5 days. RESULTS: A total of 710 patients with alleged BL allergy were evaluated. Patients with a history of immediate reaction (52, 7.3%) or cephalosporin allergy (16, 2.2%) were excluded. Of the remaining 642 patients, 62.3% had negative ST, 5.3% positive ST, and 32.4% equivocal ST. A total of 617 (96.1%) patients were challenged. Immediate reaction was observed in 9 patients (1.5%): 1-positive ST, 7-negative ST, and 1-equivocal ST (P = .7). Late reaction to the first-day challenge occurred in 24 patients (4%). An at-home challenge was continued by 491 patients. Complete 5-day and partial challenges were well tolerated by 417 (85%) and 44 patients (8.9%), respectively, disregarding ST results. Thirty patients (6.1%) developed mild reactions to the home challenge regardless of their ST results. CONCLUSION: A 5-day oral challenge without preceding ST is safe and sufficient to exclude penicillin allergy after NIR developing during penicillin treatment.


Allergens/immunology , Anaphylaxis/prevention & control , Drug Hypersensitivity/diagnosis , Hypersensitivity, Delayed/diagnosis , Penicillins/immunology , Administration, Oral , Adolescent , Adult , Aged , Aged, 80 and over , Anaphylaxis/etiology , Child , Child, Preschool , Drug Hypersensitivity/complications , Female , Humans , Hypersensitivity, Delayed/complications , Immunization , Infant , Male , Middle Aged , Practice Guidelines as Topic , Skin Tests , Young Adult
13.
Adv Chronic Kidney Dis ; 24(2): 64-71, 2017 03.
Article En | MEDLINE | ID: mdl-28284381

Drug-induced acute interstitial nephritis (DI-AIN) is a drug hypersensitivity reaction (DHR) that manifests 7 to 10 days after exposure to the culprit drug. DHRs account for fewer than 15% of reported adverse drug reactions. The kidneys are susceptible to DHR because: (1) the high renal blood flow whereby antigens are filtered, secreted, or concentrated, and (2) it is a major site of excretion for drugs and drug metabolites. More than 250 different drugs from various classes have been incriminated as causative agents of DI-AIN, the third most common cause of acute kidney injury in the hospital. DI-AIN must be differentiated from drug-induced nephrotoxic acute tubular necrosis because of their differing pathophysiology and treatment. DI-AIN begins with antigen processing and presentation to local dendritic cells. The dendritic cells activate T cells, and the subsequent effector phase of the immune response is mediated by various cytokines. Incriminated antigenic mechanisms include response to a conjugation product of the drug or its metabolite with a host protein (eg, beta-lactam or sulfonamide antibiotic) or the direct binding of the drug to a particular host allele to elicit a hypersensitivity response (eg, certain anti-epileptic drugs). If the offending drug is not identified and discontinued in a timely manner, irreversible fibrosis and chronic kidney disease will occur. The core structure of each drug or its metabolite is an antigenic determinant, and the host interaction is termed the structure-activity relationship. Differing structure-activity relationships accounts for effect, hypersensitivity, and cross-reactivity among and between classes. The essence of management of DI-AIN lies with the four sequential steps: anticipation, diagnosis, treatment, and prevention. Corticosteroids are used in the treatment of DI-AIN because of their potent anti-inflammatory effects on T cells and eosinophils. Anticipation and prevention require notifying the patient that DI-AIN is an idiosyncratic, hypersensitivity reaction that recurs on re-exposure, and the drug should be avoided.


Drug Hypersensitivity/complications , Hypersensitivity, Delayed/complications , Nephritis, Interstitial/chemically induced , Nephritis, Interstitial/immunology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Drug Hypersensitivity/therapy , Epitopes , Humans , Hypersensitivity, Delayed/therapy , Nephritis, Interstitial/therapy , Proton Pump Inhibitors/adverse effects , Sulfonamides/adverse effects , beta-Lactams/adverse effects
14.
BMJ Case Rep ; 20172017 Feb 20.
Article En | MEDLINE | ID: mdl-28219914

Metal-induced encephalopathy after stent-assisted coil embolization is extremely rare. The present report describes two patients who presented with symptomatic intracranial parenchymal edematous lesions after stent-assisted coil embolization. A 64-year-old woman underwent stent-assisted coil embolization for a left internal carotid artery aneurysm; 21 days after the procedure she presented with right hand weakness and MRI revealed multifocal white matter lesions. Another woman aged 52 years underwent stent-assisted coil embolization for right vertebral artery aneurysm; 18 days after the procedure she presented with left-sided sensory disturbance and MRI demonstrated multiple white matter lesions. Treatment in both cases resulted in improvement of these lesions after steroid pulse therapy, and the patients had no associated morbidity 4 months after the procedures. Clinicians should monitor for neurologic symptoms and postoperative delayed radiologic parenchymal edematous changes associated with the metal allergic reaction after nitinol stent-assisted coil embolization.


Brain Diseases/immunology , Embolization, Therapeutic/adverse effects , Intracranial Aneurysm/therapy , Stents/adverse effects , Alloys/adverse effects , Brain Diseases/diagnostic imaging , Female , Humans , Hypersensitivity, Delayed/complications , Magnetic Resonance Imaging , Middle Aged , Nickel/immunology , White Matter/diagnostic imaging
15.
J Eur Acad Dermatol Venereol ; 31(4): 705-711, 2017 Apr.
Article En | MEDLINE | ID: mdl-27859670

BACKGROUND: Leprosy reactions are immunologically mediated conditions and a major cause of disability before, during and after multidrug therapy (MDT). Little data have been published on the epidemiology of leprosy reactions in Bangladesh. OBJECTIVES: To describe the pattern and prevalence of leprosy reactions in the postelimination stage. METHODS: A descriptive retrospective cross-sectional study was carried out in Chittagong Medical College Hospital using the registered records of patients in the period between 2004 and 2013. RESULTS: Of the 670 patients with leprosy, 488 (73.38%) were males and 182 (27.37%) were females. The prevalence of reaction was in 300 (44.78%) patients with a male:female ratio of 3.55 : 1. The age-specific cumulative reaction cases at >40 years were 115 (38.33%) among all age groups. The prevalence of reaction was found to be in 166 (55.33%) patients for the reversal reaction, 49 (16.57%) for the erythema nodosum leprosum (ENL) and 85 (28.33%) for the neuritis. Borderline tuberculoid was most common (106, 35.33%)in the reversal reaction group, while lepromatous leprosy was most common (37, 12.33%) in ENL group. More than half of the patients (169, 56.33%) had reactions at the time of presentations, while 85 (28.33%) and 46 (15.33%) patients developed reaction during and after MDT, respectively. The reversal reaction group presented with ≥six skin lesions in 96 (57.83%) patients and ≥two nerve function impairments (NFIs) in 107 (64.46%) patients. The ENL was present chiefly as papulo-nodular lesions in 45 (91.84%) patients followed by pustule-necrotic lesions in four (8.16%), neuritis in 33 (67.35%), fever in 24 (48.98%), lymphadenitis in six (12.24%), arthritis in five (10.20%) and iritis in two (4.08%). Bacterial index ≥3 had been demonstrated in 34 (60.71%) patients in ENL group. CONCLUSION: The incidence of leprosy reaction seemed to be more than three times common in borderline tuberculoid (52.33%) group than in lepromatous leprosy (14%) group. Reactions with NFI and disability still occur among multibacillary patients during and after MDT. Early detection and management of leprosy reaction are very important in preventing disability and deformity, and patients should be educated to undergo regular follow-up examinations. Developing reinforced new therapies to curb leprosy reactions is crucial for improving leprosy healthcare services.


Erythema Nodosum/immunology , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/epidemiology , Leprosy/drug therapy , Lymphadenitis/immunology , Neuritis/immunology , Adolescent , Adult , Antigens, Bacterial/immunology , Arthritis/epidemiology , Arthritis/immunology , Bangladesh/epidemiology , Child , Child, Preschool , Erythema Nodosum/epidemiology , Female , Humans , Infant , Iritis/epidemiology , Iritis/immunology , Leprostatic Agents/therapeutic use , Leprosy, Borderline/drug therapy , Leprosy, Lepromatous/drug therapy , Leprosy, Tuberculoid/drug therapy , Lymphadenitis/epidemiology , Male , Neuritis/epidemiology , Prevalence , Retrospective Studies , Young Adult
17.
Arch. esp. urol. (Ed. impr.) ; 69(2): 89-91, mar. 2016. ilus
Article Es | IBECS | ID: ibc-149162

OBJETIVO: Conocer los efectos secundarios dermatológicos del tratamiento con Mitomicina C endovesical en el cáncer de vejiga no músculo invasivo. MÉTODOS: Se describen dos casos de dermatitis palmo plantar durante dicho tratamiento. RESULTADO: Se describen dos tipos de etiopatogenia en dermatitis durante el tratamiento con Mitomicina C endovesical, dermatitis por contacto y dermatitis por hipersensibilidad retardada. CONCLUSIONES: La dermatitis por contacto de etiología no alérgica es un efecto secundario frecuente, se han descrito muchos casos en la literatura, por otro lado existe la dermatitis por mecanismo de hipersensibilidad retardada tipo IV es mucho menos frecuente y requiere tratamiento con corticoesteroides


OBJECTIVE: To know the dermatologic side effects of intravesical treatment with Mitomycin C in non muscle invasive bladder cancer. METHODS: We describe two cases of palm and plantar dermatitis after such treatment. RESULTS: We describe two types of dermatitis pathogenesis during treatment with intravesical Mitomycin C: contact dermatitis and delayed hypersensitivity dermatitis. CONCLUSIONS: Contact dermatitis of non-allergic origin is a common side effect described in many instances in the literature, on the other hand exists dermatitis secondary to delayed hypersensitivity type IV much less common, requiring treatment with corticosteroids


Humans , Male , Middle Aged , Mitomycin/adverse effects , Dermatitis/complications , Dermatitis/diagnosis , Hypersensitivity, Delayed/chemically induced , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/diagnosis , Adrenal Cortex Hormones/therapeutic use , Administration, Intravesical , Cystoscopy/instrumentation , Cystoscopy/methods , Cystoscopy , Erythema/chemically induced , Erythema/complications , Erythema/drug therapy
18.
Allergol. immunopatol ; 44(1): 83-95, ene.-feb. 2016. ilus, graf
Article En | IBECS | ID: ibc-147488

Severe delayed drug-induced skin reactions in children are not common but potentially serious. This article describes aspects concerning the etiology, pathogenesis and clinical manifestations of these processes; it presents three paediatric cases, namely STS (Steven Johnson Syndrome), TEN (toxic epidermal necrolysis), probably related to amoxicillin/clavulanate and ibuprofen and DRESS (a drug reaction with eosinophilia and systemic symptoms) secondary to phenytoin; and in relation to them, the diagnosis and the treatment of these processes are discussed and reviewed. The AGEP (acute generalised exanthematous pustulosis) is also reviewed. The aetiological diagnosis of severe non-immediate reactions is difficult, and the value of current allergological testing is not well defined in these cases. Diagnosis is based on clinical history, the empirical risk of drugs to trigger SJS/TEN or DRESS, and the in vivo and in vitro testing of the suspect drug. Skin biopsy confirms that the clinical diagnosis and delayed hypersensitivity tests, especially the patch test and the lymphoblastic transformation test (LTT), may be important to confirm the aetiological diagnosis, in our cases emphasising the latter. These diseases can be life threatening (especially DRESS and TEN) and/or have a high rate of major complications or sequelae (SJS/TEN). The three cases described progressed well without sequelae. All were treated with corticosteroids, which is the most currently accepted treatment although the effect has not been clearly demonstrated


No disponible


Infant , Child , Humans , Skin Tests/methods , Dermatitis, Contact/complications , Dermatitis, Contact/diagnosis , Dermatitis, Contact/immunology , Drug Hypersensitivity/complications , Drug Hypersensitivity/immunology , Sinusitis/complications , Sinusitis/drug therapy , Hypersensitivity, Delayed/complications , Hypersensitivity, Delayed/immunology , Stevens-Johnson Syndrome/complications , Amoxicillin-Potassium Clavulanate Combination/adverse effects , Ibuprofen/adverse effects
...